O vs STRO
Realty Income Corporation (O) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
O currently screens at market cap $56.48B and trailing P/E 49.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the O and STRO stock pages for the full models.
Not investment advice.